New products of the Congressional Research Service that have not been made readily available to the public include these:
Major U.S. Arms Sales and Grants to Pakistan Since 2001, July 25, 2012
Direct Overt U.S. Aid and Military Reimbursements to Pakistan, FY2002-FY2013, July 27, 2012
Georgia [Republic]: Recent Developments and U.S. Interests, July 13, 2012
The Proposed Anti-Counterfeiting Trade Agreement: Background and Key Issues, July 19, 2012
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.